Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Medication Safety Topic Center

Featured Article

Poll
Pharmacy Benefit Managers vs Independent Pharmacies
03/25/2024
03/25/2024
Pharmacy Learning Network
Quiz
Reviewing the Stop Dangerous Pharmacies Act
03/07/2024
What is the Stop Dangerous Pharmacies Act?
What is the Stop Dangerous Pharmacies Act?
What is the Stop Dangerous...
03/07/2024
Pharmacy Learning Network
News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
Poll
Ensuring Safe and Effective Use of Weight Loss Drugs
03/01/2024
03/01/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network

Newsfeed

News
Global GLP-1 Agonist Market Trends
03/04/2024

Emry Lloyd

Emry Lloyd
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report was released, and new information was discussed on the global glucagon-like peptide 1 (GLP-1) agonist market. The GLP-1 market has shown a steady increase of 20.6% CAGR between 2020 and 2023.
The 2024 Market Research Report...
03/04/2024
Pharmacy Learning Network
News
Subpotent Eye Solution Recalled
09/21/2023
Jolynn Tumolo
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries Inc is recalling two lots of a prescription ophthalmic solution indicated to increase tear production in patients with dry eye.
Sun Pharmaceutical Industries...
09/21/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Jolynn Tumolo
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Antifungal Injection Recalled
07/07/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
Jolynn Tumolo
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Class I Recall for Contaminated Hand Sanitizers
06/23/2023
Jolynn Tumolo
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued for a variety of alcohol antiseptic hand sanitizers due to methanol contamination.
A Class I recall has been issued...
06/23/2023
Pharmacy Learning Network
News
Anticonvulsant Capsules Recalled
06/23/2023
Jolynn Tumolo
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been issued for more than 9000 bottles of extended phenytoin sodium capsules after dissolution testing of the product showed results above specification.
A Class II recall has been...
06/23/2023
Pharmacy Learning Network
News
Antifibrinolytic Drug Recalled
06/23/2023
Jolynn Tumolo
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two firms for antifibrinolytic drug tablets, distributed throughout the United States, for failing to meet impurity/degradation specifications.
A recall has been issued by two...
06/23/2023
Pharmacy Learning Network
News
Injection Recalled After Manufacturer Halts Quality Program
06/16/2023
Jolynn Tumolo
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been issued for a prescription injection anticholinergic/antispasmodic drug due to the manufacturer discontinuing their quality assurance program.
A Class II recall has been...
06/16/2023
Pharmacy Learning Network
News
Recall for Prescription Toothpaste
09/19/2024
A label mix-up has prompted Elevate Oral Care to recall a lot of Just Right 5000 toothpaste.
A label mix-up has prompted Elevate Oral Care to recall a lot of Just Right 5000 toothpaste.
A label mix-up has prompted...
09/19/2024
Pharmacy Learning Network
News
Skin Cream Recalled for Microbial Contamination
09/19/2024
Prequel Skin is recalling more than 30 000 tubes of Barrier Therapy Skin Protectant Cream because of microbial contamination.
Prequel Skin is recalling more than 30 000 tubes of Barrier Therapy Skin Protectant Cream because of microbial contamination.
Prequel Skin is recalling more...
09/19/2024
Pharmacy Learning Network
News
Revolutionary Cell Therapy May Eliminate Need for Immunosuppressants in Liver Transplant Recipients
09/16/2024
Donor immune cells may reduce or eliminate the need for immunosuppressants in liver transplant recipients, potentially revolutionizing post-transplant care, according to a study published in Science Translational Medicine.
Donor immune cells may reduce or eliminate the need for immunosuppressants in liver transplant recipients, potentially revolutionizing post-transplant care, according to a study published in Science Translational Medicine.
Donor immune cells may reduce or...
09/16/2024
Pharmacy Learning Network
News
Recall for Tablets Distributed in 2 States
09/13/2024
Preferred Pharmaceuticals Inc. is recalling 266 bottles of ibuprofen tablets distributed in California and Nevada, according to the September 4, 2024, US Food and Drug Administration (FDA) Enforcement Report. The affected tablets failed to...
Preferred Pharmaceuticals Inc. is recalling 266 bottles of ibuprofen tablets distributed in California and Nevada, according to the September 4, 2024, US Food and Drug Administration (FDA) Enforcement Report. The affected tablets failed to...
Preferred Pharmaceuticals Inc....
09/13/2024
Pharmacy Learning Network
News
Impurity Prompts Tablet Recall
09/13/2024
Dr Reddy’s Laboratories Inc. is recalling 150 040 bottles of IBU (ibuprofen) tablets because of an unknown impurity. According to the September 4, 2024, US Food and Drug Administration (FDA) Enforcement Report, testing revealed impurity...
Dr Reddy’s Laboratories Inc. is recalling 150 040 bottles of IBU (ibuprofen) tablets because of an unknown impurity. According to the September 4, 2024, US Food and Drug Administration (FDA) Enforcement Report, testing revealed impurity...
Dr Reddy’s Laboratories Inc. is...
09/13/2024
Pharmacy Learning Network
News
Drug Recalled for Failing Dissolution Testing
09/13/2024
Glenmark Pharmaceuticals Inc. USA is recalling 2404 bottles of indomethacin extended-release capsules distributed throughout the United States by Taro Pharmaceuticals USA, Hawthorne, New York. According to the September 4, 2024, US Food and...
Glenmark Pharmaceuticals Inc. USA is recalling 2404 bottles of indomethacin extended-release capsules distributed throughout the United States by Taro Pharmaceuticals USA, Hawthorne, New York. According to the September 4, 2024, US Food and...
Glenmark Pharmaceuticals Inc....
09/13/2024
Pharmacy Learning Network
News
Comprehensive Review Reveals Substantial Burden of Respiratory Syncytial Virus in Adults Worldwide
09/10/2024
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
Class I Recall for Intravenous Solution
08/28/2024
B. Braun Medical Inc. is recalling over 60 000 containers of 0.9% sodium chloride injection for the potential presence of particulate matter and fluid leakage.
B. Braun Medical Inc. is recalling over 60 000 containers of 0.9% sodium chloride injection for the potential presence of particulate matter and fluid leakage.
B. Braun Medical Inc. is...
08/28/2024
Pharmacy Learning Network
News
Label Mix-Up Prompts Class I Recall for Injection
08/28/2024
Hikma Pharmaceuticals USA Inc. is recalling over 30 000 bags of acetaminophen injection after a bag labeled dexmedetomidine HCl injection was found inside an overwrap labeled acetaminophen injection.
Hikma Pharmaceuticals USA Inc. is recalling over 30 000 bags of acetaminophen injection after a bag labeled dexmedetomidine HCl injection was found inside an overwrap labeled acetaminophen injection.
Hikma Pharmaceuticals USA Inc....
08/28/2024
Pharmacy Learning Network
News
OTC Migraine Relief Tablets Under Class I Recall
08/28/2024
Aurobindo Pharma USA Inc., on behalf of AuroHealth, is recalling bottles of Healthy Living migraine relief tablets because bottles sold through Amazon are missing the manufacturer’s label, including drug fact information.
Aurobindo Pharma USA Inc., on behalf of AuroHealth, is recalling bottles of Healthy Living migraine relief tablets because bottles sold through Amazon are missing the manufacturer’s label, including drug fact information.
Aurobindo Pharma USA Inc., on...
08/28/2024
Pharmacy Learning Network

Advertisement

Insights

Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
More Evidence of Cardiovascular Harm With NSAIDs
04/13/2023
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.
In light of a new study, Dr Jennings advocates for practicing pharmacists to discuss the potential cardiovascular harm associated with short-term use of nonsteroidal anti-inflammatory drugs.
In light of a new study, Dr...
04/13/2023
Pharmacy Learning Network
Commentary
Check Twice, Jab Once: How to Make Sure You Are Administering the Correct Vaccine
03/06/2023

Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices

Tyler Nichols, PharmD, BCPS, internat...
In this commentary, Tyler Nichols, PharmD, discusses common causes of vaccine errors and shares strategies for reducing risk, including storage best practices, technological solutions, and more.
In this commentary, Tyler Nichols, PharmD, discusses common causes of vaccine errors and shares strategies for reducing risk, including storage best practices, technological solutions, and more.
In this commentary, Tyler...
03/06/2023
Pharmacy Learning Network
Stock image of an open pill bottle with medication spilling out in a pharmacy.
Commentary
Drug Diversion and Leadership Response: Tips for Supporting Staff, Patients
02/01/2023

Sadik Owolewa, PharmD, 2022-2023 FDA/ISMP safe medication management fellow

Sadik Owolewa, PharmD, 2022-2023 FDA/...
In this commentary, Sadik Owolewa, PharmD, shares 5 strategies for preventing drug diversion with an emphasis on supporting health care workers, promoting a safe environment, and educating patients.
In this commentary, Sadik Owolewa, PharmD, shares 5 strategies for preventing drug diversion with an emphasis on supporting health care workers, promoting a safe environment, and educating patients.
In this commentary, Sadik...
02/01/2023
Pharmacy Learning Network
Stock image of eye and ear drops.
Commentary
An Eye (Drop) for an Eye, and an Ear (Drop) for an Ear
12/22/2022

Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices

Tyler Nichols, PharmD, BCPS, internat...
Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices, reviews an incident where ear drops were administered in a patient's eye mistakenly and advises what steps may be taken to...
Tyler Nichols, PharmD, BCPS, international safe medication management fellow, Institute for Safe Medication Practices, reviews an incident where ear drops were administered in a patient's eye mistakenly and advises what steps may be taken to...
Tyler Nichols, PharmD, BCPS,...
12/22/2022
Pharmacy Learning Network
Stock image of a pharmacist holding a prescription and bottle of medication
Commentary
Conflict Management: I Don't Remember Learning This in Pharmacy School
12/14/2022

Jose Nery, PharmD, 2022-2023 ISMP Safe Medication Management Fellow

Jose Nery, PharmD, 2022-2023 ISMP Saf...
Jose Nery, PharmD, a 2022-2023 safe medication management fellow with ISMP, shares guidance for pharmacists hoping to better navigate conflict with prescribers while addressing concerns over the safety of an order.
Jose Nery, PharmD, a 2022-2023 safe medication management fellow with ISMP, shares guidance for pharmacists hoping to better navigate conflict with prescribers while addressing concerns over the safety of an order.
Jose Nery, PharmD, a 2022-2023...
12/14/2022
Pharmacy Learning Network
Headshot of Reetu Mukherji, MD, Georgetown University
Interview
Evaluating a Digital Tool for Monitoring Drug Toxicities in Patients With Colorectal Cancer
12/12/2022
Maria Asimopoulos
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD,...
12/12/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Still Seeking Answers for Safe Anticoagulation in Patients on Hemodialysis
12/08/2022
Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study comparing apixaban to warfarin in patients with atrial fibrillation who received hemodialysis for end-stage kidney disease.
Dr Jennings reviews a study...
12/08/2022
Pharmacy Learning Network
Headshot of Stephanie Ostling Mason, Glytec, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Improving Glycemic Management for Better Outcomes, Cost Savings
12/07/2022
Maria Asimopoulos
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD,...
12/07/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Underutilization of Pharmacists
07/13/2022
Mark Munger, PharmD, FCCP, FACC, FHFSA
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this series, Dr Munger discusses why pharmacists are uniquely equipped to employ strategies that improve medication safety.  
In the final installment of this...
07/13/2022
Pharmacy Learning Network
Headshot of Mark Munger, PharmD, University of Utah
Commentary
A Series on Medication Safety in the United States: Effective Strategies to Enhance Safety
07/06/2022
Mark Munger, PharmD, FCCP, FACC, FHFSA
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of this series, Dr Munger shares strategies for providers and health systems to improve medication safety.
In the second installment of...
07/06/2022
Pharmacy Learning Network

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Advertisement

Video Insights

Examining Pharmacy Dispensing, Medication Safety Amid COVID-19
Videos
Examining Pharmacy Dispensing, Medication Safety Amid COVID-19
04/09/2020
Matthew Grissinger, RPh, director of error reporting, ISMP, discusses cross-contamination risk of COVID-19 when handling medications and provides tips to help mitigate this risk.
Matthew Grissinger, RPh, director of error reporting, ISMP, discusses cross-contamination risk of COVID-19 when handling medications and provides tips to help mitigate this risk.
Matthew Grissinger, RPh,...
04/09/2020
Pharmacy Learning Network
Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement